HomeBUSINESS
BUSINESS

Takeda Spin-Off Chordia Concludes Investment Contract with Takeda, Venture Capitals
(Nov.27.2017)

Chordia Therapeutics, a biotech company launched by six former scientists of Takeda Pharmaceutical in October, has concluded a third-party share allocation agreement with Takeda and venture capitals, the company said on November 22 ...
(LOG IN FOR FULL STORY)